LEADER 05500nam 2200637Ia 450 001 9910462927703321 005 20200520144314.0 010 $a1-61705-167-5 035 $a(CKB)2670000000387535 035 $a(EBL)1218688 035 $a(OCoLC)851972264 035 $a(SSID)ssj0000915798 035 $a(PQKBManifestationID)12377231 035 $a(PQKBTitleCode)TC0000915798 035 $a(PQKBWorkID)10868704 035 $a(PQKB)11172593 035 $a(MiAaPQ)EBC1218688 035 $a(Au-PeEL)EBL1218688 035 $a(CaPaEBR)ebr10720897 035 $a(CaONFJC)MIL539956 035 $a(EXLCZ)992670000000387535 100 $a20130130d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGynecologic oncology handbook$b[electronic resource] $ean evidence-based clinical guide /$fMichelle F. Benoit, Marian Yvette Williams-Brown, Creighton L. Edwards 210 $aNew York, NY $cDemos Medical Publising, LLC$dc2013 215 $a1 online resource $cillustrations 300 $aDescription based upon print version of record. 311 $a1-62070-005-0 320 $aIncludes bibliographical references and index. 327 $aCover; Title; Copyright; Contents; Preface; Chapter 1: Gynecologic Oncology Referral Parameters; I. Endometrial Cancer; II. Pelvic Mass; III. Cervical Cancer; IV. Vaginal Cancer; V. Vulvar Cancer; VI. Gestational Trophoblastic Disease; Chapter 2: Disease Sites; A: Preinvasive Disease; I. Cervical Intraepithelial Neoplasia (CIN); II. Vulvar Intraepithelial Neoplasia; III. Vaginal Intraepithelial Neoplasia (VAIN); IV. Dysplasia and HIV; References; B: Cervical Cancer; I. Characteristics; II. Pretreatment Workup; III. Histology; IV. Staging; V. Overall survival by stage; VI. Treatment 327 $aVII. Surgical TreatmentVIII. Radiotherapy; IX. Adjuvant Posthysterectomy Treatment; X. Advanced Disease; XI. Recurrent Disease; XII. Survival; XIII. Prognostic Factors for Survival; XIV. Follow-Up; XV. Notable Trials in Cervical Cancer; References; C: Ovarian Cancer; I. General Characteristics; II. General Workup; III. General Treatment; IV. Histology; V. General Staging; Epithelial Ovarian Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Chemotherapy for Epithelial Ovarian Cancer; VII. Treatment by Stage; VIII. Second-look laparotomy; IX. Recurrence 327 $aX. Secondary cytoreductionXI. Cerebellar degeneration; XII. Survival; XIII. Survival Care; XIV. Epithelial Ovarian Cancer Trials; Ovarian Tumors of Low Malignant Potential (LMP); I. Characteristics; II. Histology; III. Workup; IV. Staging; V. Treatment; VI. Recurrence; VII. Survival; VIII. Survival Care; Fallopian Tube Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Survival; VII. Survival care; Primary Peritoneal Cancer; Germ Cell Tumors (GCT); I. Characteristics; II. Workup; III. Staging; IV. Treatment; V. Recurrence; VI. Follow-Up 327 $aVII. Histological Subtypes and Directed TherapiesVIII. Germ Cell Tumor Trials; IX. Chemotherapy Protocols for Ovarian GCT; Sex Cord Stromal Tumors; I. Characteristics; II. Workup; III. Staging; IV. Treatment; V. Histology; VI. 5 Y Survival; VII. Sex Cord Stromal Tumor Trials; References; D: Uterine Cancer; I. Characteristics; II. Prognostic factors; III. Pretreatment Workup; IV. Histology; V. Staging; VI. Grade is specified as a 3-tiered system; VII. Treatment; VIII. Recurrence; IX. Postoperative hormonal replacement therapy; X. Synchronous ovarian neoplasm; XI. Survival; XII. Follow-Up 327 $aXIII. TamoxifenNotable Studies in Uterine Cancer; I. High-Risk Early-Stage Disease Adjuvant Therapy Studies; Uterine Sarcomas; I. Characteristics; V. Prognostic factors; VI. Follow-Up; References; E: Vulvar Cancer; I. Characteristics; II. Workup; III. Histology; IV. Staging; V. Treatment; VI. Recurrence; VII. Survival; VIII. Follow-up; Notable Studies; References; F: Vaginal Cancer; I. Characteristics; II. Pretreatment Workup; III. Histology; IV. Staging; V. Treatment; VI. Recurrent Disease; VII. Survival; VIII. Follow-up; G: Gestational Trophoblastic Disease; I. Characteristics 327 $aII. Histology 330 $aGynecologic Oncology Rotation Quick Reference provides a comprehensive yet concise, practical guide for fellows, residents, and specialist trainees in the diagnosis and management of gynecologic cancers. The book addresses the fundamentals of gynecologic oncology, including staging, surgical technique, comorbidity diagnosis and management, adjuvant therapies including chemotherapy and radiation, and survival and palliative care. The focus is on specific management decision-making and the book provides the basic information needed to guide the clinician on the ward or in the clinic including cl 606 $aGenerative organs, Female$xCancer 606 $aEvidence-based medicine 608 $aElectronic books. 615 0$aGenerative organs, Female$xCancer. 615 0$aEvidence-based medicine. 676 $a616.99/465 700 $aBenoit$b Michelle F$01035137 701 $aWilliams-Brown$b Marian Yvette$01035138 701 $aEdwards$b Creighton L$01035139 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910462927703321 996 $aGynecologic oncology handbook$92454659 997 $aUNINA